| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | Golgi to endosome transport | 2.36e-07 | 18 | 164 | 5 | GO:0006895 | |
| GeneOntologyBiologicalProcess | gonadal mesoderm development | 4.71e-07 | 9 | 164 | 4 | GO:0007506 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 6.07e-05 | 269 | 164 | 10 | GO:0002064 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid cohesion, telomeric | 6.28e-05 | 2 | 164 | 2 | GO:0099404 | |
| GeneOntologyBiologicalProcess | maintenance of mitotic sister chromatid cohesion, telomeric | 6.28e-05 | 2 | 164 | 2 | GO:0099403 | |
| GeneOntologyBiologicalProcess | negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric | 6.28e-05 | 2 | 164 | 2 | GO:1904908 | |
| GeneOntologyBiologicalProcess | regulation of maintenance of mitotic sister chromatid cohesion, telomeric | 6.28e-05 | 2 | 164 | 2 | GO:1904907 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | ATRX ACTR5 ESR1 GPX1 TSPY3 TSPY2 TSPY8 SRCAP DICER1 TASOR2 KMT2D SF3B1 TSPY10 TAF1 SPOCD1 KAT14 DNMT3L | 8.95e-05 | 741 | 164 | 17 | GO:0006338 |
| GeneOntologyBiologicalProcess | spermatogenesis | CFAP47 BCL2L10 ATRX KCTD19 BTBD18 TSPY3 TSPY2 TSPY8 NR6A1 DICER1 ZFP37 TSPY10 HSF2 SPOCD1 AFF4 DNMT3L IQCG | 9.40e-05 | 744 | 164 | 17 | GO:0007283 |
| GeneOntologyBiologicalProcess | male gamete generation | CFAP47 BCL2L10 ATRX KCTD19 BTBD18 TSPY3 TSPY2 TSPY8 NR6A1 DICER1 ZFP37 TSPY10 HSF2 SPOCD1 AFF4 DNMT3L IQCG | 1.25e-04 | 762 | 164 | 17 | GO:0048232 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | CAND1 ATRX ACTR5 ESR1 GPX1 TSPY3 TSPY2 TSPY8 SRCAP DICER1 TASOR2 GTF2E1 KMT2D KANSL2 SF3B1 TSPY10 TAF1 SPOCD1 KAT14 DNMT3L | 1.36e-04 | 999 | 164 | 20 | GO:0071824 |
| GeneOntologyBiologicalProcess | post-embryonic forelimb morphogenesis | 1.88e-04 | 3 | 164 | 2 | GO:0035128 | |
| GeneOntologyBiologicalProcess | negative regulation of maintenance of sister chromatid cohesion | 1.88e-04 | 3 | 164 | 2 | GO:0034092 | |
| GeneOntologyBiologicalProcess | negative regulation of maintenance of mitotic sister chromatid cohesion | 1.88e-04 | 3 | 164 | 2 | GO:0034183 | |
| GeneOntologyCellularComponent | chromatin | NELFE ATRX ACTR5 ESR1 CALCOCO1 HDX ZBTB8B ETS1 TSPY3 TSPY2 E2F4 E2F5 TSPY8 NR6A1 DBP SRCAP CREB3L1 CITED2 PPP1R10 KANSL2 SF3B1 MITF TSPY10 ATF4 TAF1 HSF2 KAT14 AFF4 DNMT3L | 3.22e-06 | 1480 | 162 | 29 | GO:0000785 |
| GeneOntologyCellularComponent | costamere | 2.28e-05 | 22 | 162 | 4 | GO:0043034 | |
| GeneOntologyCellularComponent | vesicle coat | 1.72e-04 | 67 | 162 | 5 | GO:0030120 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | LPCAT1 ATP6V0A1 SGSM1 COPB1 VPS13C SEC24A TOM1 TMEM63B WASHC3 ENTHD1 ABCA7 C2CD5 AP2A1 PIK3C3 PTPRS SEC24B VPS13A SNX9 ULK2 AHNAK2 DOP1B MVB12B | 4.90e-04 | 1307 | 162 | 22 | GO:0030659 |
| GeneOntologyCellularComponent | coated vesicle | ATP6V0A1 COPB1 SEC24A ENTHD1 ECPAS F5 AP2A1 SEC24B RNF216 SNX9 | 5.18e-04 | 360 | 162 | 10 | GO:0030135 |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 5.61e-04 | 49 | 162 | 4 | GO:0099092 | |
| GeneOntologyCellularComponent | vesicle membrane | LPCAT1 ATP6V0A1 SGSM1 COPB1 VPS13C SEC24A TOM1 TMEM63B WASHC3 ENTHD1 ABCA7 C2CD5 AP2A1 PIK3C3 PTPRS SEC24B VPS13A SNX9 ULK2 AHNAK2 DOP1B MVB12B | 5.89e-04 | 1325 | 162 | 22 | GO:0012506 |
| GeneOntologyCellularComponent | super elongation complex | 8.77e-04 | 6 | 162 | 2 | GO:0032783 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 9.33e-04 | 56 | 162 | 4 | GO:0099091 | |
| Domain | Dopey_N | 7.48e-05 | 2 | 162 | 2 | PF04118 | |
| Domain | Dopey_N | 7.48e-05 | 2 | 162 | 2 | IPR007249 | |
| Domain | ARM-like | CAND1 COPB1 FRYL ECPAS SF3B1 AP2A1 STKLD1 PPP6R2 GPRASP2 KPNA2 | 1.27e-04 | 270 | 162 | 10 | IPR011989 |
| Domain | ARM-type_fold | CAND1 COPB1 FRYL ECPAS SF3B1 AP2A1 PIK3C3 STKLD1 PPP6R2 GPRASP2 KPNA2 | 1.87e-04 | 339 | 162 | 11 | IPR016024 |
| Domain | CD34_antigen | 2.23e-04 | 3 | 162 | 2 | PF06365 | |
| Domain | CD34/Podocalyxin | 2.23e-04 | 3 | 162 | 2 | IPR013836 | |
| Domain | VPS13 | 2.23e-04 | 3 | 162 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 2.23e-04 | 3 | 162 | 2 | PF16910 | |
| Domain | VPS13 | 2.23e-04 | 3 | 162 | 2 | PF16908 | |
| Domain | VPS13_N2 | 2.23e-04 | 3 | 162 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 2.23e-04 | 3 | 162 | 2 | IPR031642 | |
| Domain | NAP_family | 3.98e-04 | 17 | 162 | 3 | IPR002164 | |
| Domain | NAP | 3.98e-04 | 17 | 162 | 3 | PF00956 | |
| Domain | SHR-BD | 4.44e-04 | 4 | 162 | 2 | IPR009543 | |
| Domain | ADD | 4.44e-04 | 4 | 162 | 2 | IPR025766 | |
| Domain | VPS13_C | 4.44e-04 | 4 | 162 | 2 | PF16909 | |
| Domain | VPS13_C | 4.44e-04 | 4 | 162 | 2 | IPR031645 | |
| Domain | ADD | 4.44e-04 | 4 | 162 | 2 | PS51533 | |
| Domain | SHR-BD | 4.44e-04 | 4 | 162 | 2 | PF06650 | |
| Domain | NUT | 7.35e-04 | 5 | 162 | 2 | IPR024310 | |
| Domain | NUT_N | 7.35e-04 | 5 | 162 | 2 | IPR024309 | |
| Domain | NUT | 7.35e-04 | 5 | 162 | 2 | PF12881 | |
| Domain | Autophagy-rel_C | 7.35e-04 | 5 | 162 | 2 | IPR015412 | |
| Domain | ATG_C | 7.35e-04 | 5 | 162 | 2 | PF09333 | |
| Domain | Sec23/24_helical_dom | 1.10e-03 | 6 | 162 | 2 | IPR006900 | |
| Domain | E2F_CC-MB | 1.10e-03 | 6 | 162 | 2 | IPR032198 | |
| Domain | Sec23_24_beta_S | 1.10e-03 | 6 | 162 | 2 | IPR012990 | |
| Domain | zf-Sec23_Sec24 | 1.10e-03 | 6 | 162 | 2 | PF04810 | |
| Domain | Sec23_trunk | 1.10e-03 | 6 | 162 | 2 | PF04811 | |
| Domain | Sec23_helical | 1.10e-03 | 6 | 162 | 2 | PF04815 | |
| Domain | Sec23_BS | 1.10e-03 | 6 | 162 | 2 | PF08033 | |
| Domain | E2F_CC-MB | 1.10e-03 | 6 | 162 | 2 | PF16421 | |
| Domain | Sec23/24_trunk_dom | 1.10e-03 | 6 | 162 | 2 | IPR006896 | |
| Domain | Znf_Sec23_Sec24 | 1.10e-03 | 6 | 162 | 2 | IPR006895 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SGSM1 CAND1 ATRX UBE4B MAP4 EPB41L4B VPS13C SPTB CALCOCO1 TOM1 CAMSAP3 CAST TMEM63B RNF213 WASHC3 FRYL ADGRV1 STK32C ECPAS TASOR2 MAPK8IP3 PIK3C3 PTPRS SNX9 SLC4A5 AFF4 FRMD3 DOP1A | 4.65e-10 | 1489 | 165 | 28 | 28611215 |
| Pubmed | DLGAP1 EGLN2 ATP6V0A1 CAND1 ANK2 ATRX COPB1 UBE4B SPTB NCAPH2 CMYA5 ST13 MAPK8IP3 KANSL2 SF3B1 SEPTIN3 AP2A1 SACS RNF216 TNKS TAF1 GPRASP2 AFF4 DOP1B | 1.07e-08 | 1285 | 165 | 24 | 35914814 | |
| Pubmed | 6.56e-08 | 74 | 165 | 7 | 24952347 | ||
| Pubmed | DLGAP1 ATP6V0A1 CAND1 ANK2 COPB1 MAP4 EPB41L4B SPTB CALCOCO1 TOM1 CAMSAP3 PSMD3 SCRN1 ST13 SHANK3 MAPK8IP3 SF3B1 AP2A1 SACS PTPRS VCAN ALB PPP6R2 ST13P5 | 8.08e-08 | 1431 | 165 | 24 | 37142655 | |
| Pubmed | NELFE CAND1 ACTR5 LRRC40 SRCAP ECPAS GTF2E1 RPAP1 KHDRBS3 TAF1 AFF4 KPNA2 | 4.04e-07 | 390 | 165 | 12 | 17643375 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DLGAP1 AGAP5 CAND1 ANK2 UBE4B CAMSAP3 SHANK3 AP2A1 SACS PHACTR1 | 1.05e-06 | 281 | 165 | 10 | 28706196 |
| Pubmed | LPCAT1 CAND1 ANK2 COPB1 MAP4 SEC24A TOM1 ECPAS PPP1R10 SEC24B SNX9 GPRASP2 | 1.76e-06 | 449 | 165 | 12 | 31732153 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NELFE FAM193B CAND1 ANK2 ATRX COPB1 MAP4 CAST SRCAP PPP1R10 GTF2E1 SF3B1 SEC24B SNX9 PPP6R2 AFF4 AHNAK2 | 2.47e-06 | 934 | 165 | 17 | 33916271 |
| Pubmed | RALGDS ATRX EPB41L4B LONP2 ENPP1 CAMSAP3 GMIP DICER1 LPIN1 FREM2 RPAP1 RNF216 TNFAIP2 PPP6R2 | 2.99e-06 | 650 | 165 | 14 | 38777146 | |
| Pubmed | DLGAP1 CAND1 ANK2 PDE1B CALCOCO1 CAMSAP3 SHANK3 MAPK8IP3 SF3B1 SEPTIN3 AP2A1 PTPRS TNKS PPP6R2 CDH11 AFF4 PHACTR1 | 3.71e-06 | 963 | 165 | 17 | 28671696 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 4.64e-06 | 332 | 165 | 10 | 32786267 | |
| Pubmed | Canonical and atypical E2Fs regulate the mammalian endocycle. | 5.77e-06 | 8 | 165 | 3 | 23064266 | |
| Pubmed | DLGAP1 ATP6V0A1 ANK2 MAP4 CAMSAP3 C2CD5 MAPK8IP3 AP2A1 SACS PPP6R2 | 6.84e-06 | 347 | 165 | 10 | 17114649 | |
| Pubmed | 8.63e-06 | 9 | 165 | 3 | 35296311 | ||
| Pubmed | Proteolysis of MLL family proteins is essential for taspase1-orchestrated cell cycle progression. | 8.63e-06 | 9 | 165 | 3 | 16951254 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 9.11e-06 | 283 | 165 | 9 | 30585729 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | FAM193B ATRX PODXL ESR1 MUC16 RNF213 STK32C FREM2 KMT2D SF3B1 VPS13A TAF1 | 1.42e-05 | 552 | 165 | 12 | 10737800 |
| Pubmed | ATP6V0A1 MAP4 SEC24A CAMSAP3 WASHC3 ABCA7 SEC24B BCL10 SPINDOC AHNAK2 | 1.43e-05 | 378 | 165 | 10 | 34315543 | |
| Pubmed | LPCAT1 ANK2 MAP4 DBP ECPAS DICER1 CREB3L1 SF3B1 PIK3C3 VPS13A TNKS FTO | 1.88e-05 | 568 | 165 | 12 | 9110174 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | CAND1 COPB1 UBE4B MAP4 SEC24A TOM1 GPX1 CAST ISOC1 PSMD3 SCRN1 FRYL CMYA5 ECPAS ST13 GTF2E1 UBXN7 FTO AHNAK2 KPNA2 | 2.03e-05 | 1455 | 165 | 20 | 22863883 |
| Pubmed | A "double adaptor" method for improved shotgun library construction. | LPCAT1 ANK2 MAP4 DBP ECPAS DICER1 CREB3L1 SF3B1 PIK3C3 VPS13A TNKS FTO | 2.09e-05 | 574 | 165 | 12 | 8619474 |
| Pubmed | An inter-species protein-protein interaction network across vast evolutionary distance. | FAM193B TRIM41 CALCOCO1 WASHC3 NCAPH2 CREB3L1 TASOR2 KHDRBS3 ATF4 SNX9 GPRASP2 | 2.14e-05 | 483 | 165 | 11 | 27107014 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ANKRD13D FAM193B UBE4B FRYL STK32C SRCAP ABCA7 MAPK8IP3 TBC1D16 KMT2D RPAP1 AP2A1 PTPRS TNFAIP2 ULK2 AHNAK2 MVB12B | 2.20e-05 | 1105 | 165 | 17 | 35748872 |
| Pubmed | CAND1 COPB1 EPB41L4B PODXL VPS13C SEC24A MUC16 RNF213 PODXL2 TASOR2 SF3B1 SEC24B VPS13A ALB | 2.22e-05 | 777 | 165 | 14 | 35844135 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 29103441 | ||
| Pubmed | Synapse structure: glutamate receptors connected by the shanks. | 2.24e-05 | 2 | 165 | 2 | 10574750 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 26122040 | ||
| Pubmed | E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. | 2.24e-05 | 2 | 165 | 2 | 11030352 | |
| Pubmed | Glucose availability controls ATF4-mediated MITF suppression to drive melanoma cell growth. | 2.24e-05 | 2 | 165 | 2 | 28380427 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 10931277 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 27519661 | ||
| Pubmed | St13 protects against disordered acinar cell arachidonic acid pathway in chronic pancreatitis. | 2.24e-05 | 2 | 165 | 2 | 35562743 | |
| Pubmed | Brain-specific transcript variants of 5' and 3' ends of mouse VPS13A and VPS13C. | 2.24e-05 | 2 | 165 | 2 | 17196930 | |
| Pubmed | The ESR1 and GPX1 gene expression level in human malignant and non-malignant breast tissues. | 2.24e-05 | 2 | 165 | 2 | 29543921 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 23874775 | ||
| Pubmed | Lineage-specific transcriptional regulation of DICER by MITF in melanocytes. | 2.24e-05 | 2 | 165 | 2 | 20550935 | |
| Pubmed | Somatic mutations of DICER1 and KMT2D are frequent in intraocular medulloepitheliomas. | 2.24e-05 | 2 | 165 | 2 | 26841698 | |
| Pubmed | 2.47e-05 | 246 | 165 | 8 | 15345747 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CAND1 COPB1 MAP4 PSMD3 LRRC40 SRCAP F5 DICER1 PPP1R10 SF3B1 RPAP1 AP2A1 SACS ALB SNX9 KPNA2 | 3.22e-05 | 1024 | 165 | 16 | 24711643 |
| Pubmed | CAND1 COPB1 LONP2 GPX1 HDX CAMSAP3 PSMD3 GMIP ECPAS ST13 PPP1R10 AP2A1 TNKS SNX9 KPNA2 | 3.38e-05 | 916 | 165 | 15 | 32203420 | |
| Pubmed | ESR1 ZBTB8B ETS1 E2F4 E2F5 NR6A1 SRCAP ZNF623 ZFP37 CITED2 PPP1R10 GTF2E1 ATF4 DOP1B | 3.40e-05 | 808 | 165 | 14 | 20412781 | |
| Pubmed | DLGAP1 ENPP1 ESR1 SPTB PYROXD2 ETS1 SCRN1 ADGRV1 CITED2 GTF2E1 SUSD1 PIK3C3 UBXN7 MVB12B | 3.68e-05 | 814 | 165 | 14 | 23251661 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | EAF2 COPB1 SEC24A TOM1 APBA3 GMIP LPIN1 RPAP1 AP2A1 YAE1 SEC24B MITF RNF216 TNKS BCL10 PPP6R2 | 3.79e-05 | 1038 | 165 | 16 | 26673895 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 3.95e-05 | 341 | 165 | 9 | 32971831 | |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 4.07e-05 | 264 | 165 | 8 | 32814769 | |
| Pubmed | 4.59e-05 | 197 | 165 | 7 | 36604605 | ||
| Pubmed | CASP8AP2 RALGDS AGAP5 CAND1 VPS13C SCRN1 ADGRV1 ECPAS DICER1 UBXN7 FTO | 4.88e-05 | 529 | 165 | 11 | 14621295 | |
| Pubmed | 5.22e-05 | 43 | 165 | 4 | 26030138 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CFAP47 SGSM1 EPB41L4B VPS13C CAMSAP3 RNF213 LRRC40 ECPAS FREM2 RPAP1 VPS13A ALB DOP1B | 5.38e-05 | 736 | 165 | 13 | 29676528 |
| Pubmed | EGLN2 CAND1 COPB1 CALCOCO1 MIER3 CAST ADGRV1 SEPTIN3 AP2A1 MITF RNF216 KLHL18 IQCG | 6.50e-05 | 750 | 165 | 13 | 11230166 | |
| Pubmed | VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites. | 6.69e-05 | 3 | 165 | 2 | 30093493 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 20551905 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 26373281 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 21720911 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 37567906 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 33811251 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 15855772 | ||
| Pubmed | A PIK3C3-ankyrin-B-dynactin pathway promotes axonal growth and multiorganelle transport. | 6.69e-05 | 3 | 165 | 2 | 25533844 | |
| Pubmed | The pro-death role of Cited2 in stroke is regulated by E2F1/4 transcription factors. | 6.69e-05 | 3 | 165 | 2 | 30967472 | |
| Pubmed | Regulated vesicular trafficking of specific PCDH15 and VLGR1 variants in auditory hair cells. | 6.69e-05 | 3 | 165 | 2 | 23035094 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 21951999 | ||
| Pubmed | Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids. | 6.69e-05 | 3 | 165 | 2 | 30500538 | |
| Pubmed | Interplay between the retinoblastoma related pRb2/p130 and E2F-4 and -5 in relation to JCV-TAg. | 6.69e-05 | 3 | 165 | 2 | 17385710 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 15342491 | ||
| Pubmed | TRIM41 is required to innate antiviral response by polyubiquitinating BCL10 and recruiting NEMO. | 6.69e-05 | 3 | 165 | 2 | 33640899 | |
| Pubmed | TBC1D1 interacting proteins, VPS13A and VPS13C, regulate GLUT4 homeostasis in C2C12 myotubes. | 6.69e-05 | 3 | 165 | 2 | 33087848 | |
| Pubmed | E2f4 and E2f5 are essential for the development of the male reproductive system. | 6.69e-05 | 3 | 165 | 2 | 26825228 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 26958016 | ||
| Pubmed | Mon2, a relative of large Arf exchange factors, recruits Dop1 to the Golgi apparatus. | 6.69e-05 | 3 | 165 | 2 | 16301316 | |
| Pubmed | CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells. | 6.69e-05 | 3 | 165 | 2 | 30145202 | |
| Pubmed | Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elements. | 6.79e-05 | 17 | 165 | 3 | 11245978 | |
| Pubmed | Mice deficient in LMAN1 exhibit FV and FVIII deficiencies and liver accumulation of α1-antitrypsin. | 6.79e-05 | 17 | 165 | 3 | 21795745 | |
| Pubmed | MAP4 HDX CAMSAP3 PSMD3 FRYL TASOR2 SF3B1 KHDRBS3 ALB SPINDOC KPNA2 | 7.01e-05 | 551 | 165 | 11 | 34728620 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 7.29e-05 | 212 | 165 | 7 | 33853758 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | DLGAP1 ATRX CALCOCO1 FRYL STK32C SHANK3 AXIN2 TASOR2 MAPK8IP3 KANSL2 KHDRBS3 | 8.09e-05 | 560 | 165 | 11 | 21653829 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NELFE ATRX UBE4B MAP4 CAMSAP3 CAST ECPAS C2CD5 MAPK8IP3 KMT2D KANSL2 SF3B1 RPAP1 | 8.91e-05 | 774 | 165 | 13 | 15302935 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | NELFE ANKRD13D AGAP5 SGSM1 SEC24A CAMSAP3 NUTM2D FRYL NCAPH2 CREB3L1 NUTM2G VPS13A FTO NUTM2F KLHL18 KAT14 DOP1B | 9.29e-05 | 1242 | 165 | 17 | 30973865 |
| Pubmed | 1.02e-04 | 97 | 165 | 5 | 22360420 | ||
| Pubmed | Widespread macromolecular interaction perturbations in human genetic disorders. | TRIM41 WASHC3 PSMD3 NCAPH2 CREB3L1 TASOR2 KHDRBS3 BCL10 ATF4 HSF2 GPRASP2 | 1.28e-04 | 590 | 165 | 11 | 25910212 |
| Pubmed | 1.30e-04 | 102 | 165 | 5 | 9734811 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 24681956 | ||
| Pubmed | Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. | 1.33e-04 | 4 | 165 | 2 | 18463160 | |
| Pubmed | Inducing mutations in the mouse genome with the chemical mutagen ethylnitrosourea. | 1.33e-04 | 4 | 165 | 2 | 16972005 | |
| Pubmed | Intracellular trafficking and dynamics of double homeodomain proteins. | 1.33e-04 | 4 | 165 | 2 | 15709750 | |
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 16155788 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 26329844 | ||
| Pubmed | Structural basis for tankyrase-RNF146 interaction reveals noncanonical tankyrase-binding motifs. | 1.33e-04 | 4 | 165 | 2 | 29604130 | |
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 16753154 | ||
| Pubmed | Role for a novel Usher protein complex in hair cell synaptic maturation. | 1.33e-04 | 4 | 165 | 2 | 22363448 | |
| Pubmed | MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer. | 1.33e-04 | 4 | 165 | 2 | 21761362 | |
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 33009420 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 15498460 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 9736770 | ||
| Pubmed | The role of the C-terminal domain of PCSK9 and SEC24 isoforms in PCSK9 secretion. | 1.33e-04 | 4 | 165 | 2 | 32058034 | |
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 15304487 | ||
| Pubmed | The subcellular localization of E2F-4 is cell-cycle dependent. | 1.33e-04 | 4 | 165 | 2 | 9144196 | |
| Pubmed | A Genome-Wide Screen for Machinery Involved in Downregulation of MHC Class I by HIV-1 Nef. | 1.33e-04 | 4 | 165 | 2 | 26466362 | |
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 7923369 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 15701716 | ||
| Pubmed | Plasma membrane-cytoskeleton-endoplasmic reticulum complexes in neurons and astrocytes. | 1.33e-04 | 4 | 165 | 2 | 14593108 | |
| Interaction | TSPY8 interactions | 5.10e-07 | 3 | 162 | 3 | int:TSPY8 | |
| Interaction | EP300 interactions | NELFE CAND1 COPB1 MAP4 SEC24A ESR1 CALCOCO1 ETS1 PSMD3 E2F4 E2F5 NR6A1 DBP SRCAP ECPAS C2CD5 MAPK8IP3 CITED2 ZNF469 KMT2D SF3B1 AP2A1 SEC24B MITF ATF4 NUTM2F HSF2 SNX9 KPNA2 | 2.23e-06 | 1401 | 162 | 29 | int:EP300 |
| Interaction | DNMT3L interactions | 7.00e-06 | 88 | 162 | 7 | int:DNMT3L | |
| Interaction | FAM78B interactions | 1.00e-05 | 6 | 162 | 3 | int:FAM78B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 1.83e-04 | 330 | 162 | 7 | chr22q13 | |
| Cytoband | Yp11.2 | 3.56e-04 | 94 | 162 | 4 | Yp11.2 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CAND1 ATRX PODXL SEC24A TRPC1 E2F5 FRYL DICER1 C2CD5 SACS PIK3C3 UBXN7 SEC24B MITF VPS13A SERPINB2 TNKS FTO DOP1B | 1.06e-06 | 856 | 158 | 19 | M4500 |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN | 1.78e-06 | 183 | 158 | 9 | M8886 | |
| ToppCell | (08)_PNEC-(2)_48hpi|(08)_PNEC / shred by cell type and Timepoint | 8.74e-07 | 142 | 161 | 7 | e95d34170f5053678e0dd9793e68d93c03b05822 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.65e-06 | 176 | 161 | 7 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.91e-06 | 198 | 161 | 7 | cc2b5b632e73e44bb60050f0db10d8f0dbb859fa | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.45e-06 | 200 | 161 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.66e-05 | 148 | 161 | 6 | 5983c4546f527a0b599cfcbd8a6cb937a1d6f895 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.72e-05 | 149 | 161 | 6 | c5eedb54ef2e0f131aa6730612c921bc19479632 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.72e-05 | 149 | 161 | 6 | a22417286de8606f0cc94f86b70bce17aeefb9c2 | |
| ToppCell | Severe-B_naive-5|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.31e-05 | 157 | 161 | 6 | a57ee4a6febdff3ee3d1645836695e6e7c055cf8 | |
| ToppCell | Bronchial_Biopsy-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.76e-05 | 162 | 161 | 6 | 985adca17b0c99563feef7910f3da5df31e636b6 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.96e-05 | 164 | 161 | 6 | d9531848105d606adedde65426177cf851140e31 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-05 | 167 | 161 | 6 | 1e2fc1637769405a61f4c7e44945712a1888a299 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-05 | 167 | 161 | 6 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-05 | 167 | 161 | 6 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.50e-05 | 169 | 161 | 6 | 1c9e54e7b14eb99996590fb93b257cf881a9f184 | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.74e-05 | 171 | 161 | 6 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.74e-05 | 171 | 161 | 6 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.74e-05 | 171 | 161 | 6 | 714a0b0d0c9886fef64170cf53eb64f0d8a47280 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.86e-05 | 172 | 161 | 6 | c8ea80042faf923b08ff03d73100533d521d73ef | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.12e-05 | 174 | 161 | 6 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| Drug | Isopropamide iodide [71-81-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A | ATP6V0A1 ATRX MAP4 CALCOCO1 E2F4 NCAPH2 NR6A1 SRCAP ECPAS IQCG | 1.11e-06 | 196 | 157 | 10 | 3461_UP |
| Drug | Fluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A | MAP4 VPS13C ESR1 CALCOCO1 E2F4 SRCAP LPIN1 VPS13A TNFAIP2 HSF2 | 1.11e-06 | 196 | 157 | 10 | 7333_UP |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | ATP6V0A1 ATRX LONP2 SEC24A TRPC1 SPTB NCAPH2 SRCAP AHNAK2 IQCG | 1.16e-06 | 197 | 157 | 10 | 1641_UP |
| Drug | 17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 7.41e-06 | 191 | 157 | 9 | 993_UP | |
| Drug | Forskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A | 7.73e-06 | 192 | 157 | 9 | 7104_DN | |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 9.90e-06 | 198 | 157 | 9 | 4979_DN | |
| Drug | Pyrazinamide [ 98-96-4]; Down 200; 32.4uM; MCF7; HT_HG-U133A | 9.90e-06 | 198 | 157 | 9 | 2839_DN | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 4.99e-05 | 188 | 157 | 8 | 5596_UP | |
| Drug | Maprotiline hydrochloride [10347-81-6]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 5.79e-05 | 192 | 157 | 8 | 3236_UP | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 6.22e-05 | 194 | 157 | 8 | 990_DN | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 6.45e-05 | 195 | 157 | 8 | 6183_UP | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 6.45e-05 | 195 | 157 | 8 | 7435_UP | |
| Drug | Diphenidol hydrochloride [3254-89-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 6.45e-05 | 195 | 157 | 8 | 7406_UP | |
| Drug | Atracurium besylate [64228-81-5]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 7477_DN | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 7027_DN | |
| Drug | Aceclofenac [89796-99-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 7029_DN | |
| Drug | Sulfasalazine [599-79-1]; Down 200; 10uM; MCF7; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 5446_DN | |
| Drug | Sulpiride [15676-16-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 6.93e-05 | 197 | 157 | 8 | 1467_UP | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; HL60; HT_HG-U133A | 6.93e-05 | 197 | 157 | 8 | 3056_DN | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 6.93e-05 | 197 | 157 | 8 | 3515_DN | |
| Drug | Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; PC3; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 5746_UP | |
| Drug | Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 2312_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 6929_DN | |
| Drug | Cromolyn disodium salt [15826-37-6]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 3475_DN | |
| Drug | Propidium iodide [25535-16-4]; Down 200; 6uM; MCF7; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 6104_DN | |
| Drug | Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 7.18e-05 | 198 | 157 | 8 | 7349_UP | |
| Drug | Cefaclor [70356-03-5]; Up 200; 10.4uM; HL60; HT_HG-U133A | 7.44e-05 | 199 | 157 | 8 | 2483_UP | |
| Drug | N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 7.44e-05 | 199 | 157 | 8 | 959_DN | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 7.44e-05 | 199 | 157 | 8 | 3338_UP | |
| Drug | Disopyramide [3737-09-5]; Down 200; 11.8uM; HL60; HT_HG-U133A | 7.44e-05 | 199 | 157 | 8 | 2408_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A | 7.44e-05 | 199 | 157 | 8 | 5575_DN | |
| Drug | Aminophylline [317-34-0]; Up 200; 9.6uM; PC3; HT_HG-U133A | 7.44e-05 | 199 | 157 | 8 | 6295_UP | |
| Drug | Yohimbinic acid monohydrate [27801-27-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 7.44e-05 | 199 | 157 | 8 | 2803_DN | |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; HL60; HT_HG-U133A | 7.44e-05 | 199 | 157 | 8 | 2199_UP | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; PC3; HT_HG-U133A | 7.44e-05 | 199 | 157 | 8 | 5879_DN | |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 2.71e-05 | 2 | 154 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 2.71e-05 | 2 | 154 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 8.09e-05 | 3 | 154 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 8.09e-05 | 3 | 154 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | Male Germ Cell Tumor | 1.61e-04 | 4 | 154 | 2 | C3496549 | |
| Disease | cardiovascular system disease (is_implicated_in) | 1.73e-04 | 21 | 154 | 3 | DOID:1287 (is_implicated_in) | |
| Disease | Antithrombotic agent use measurement | 1.98e-04 | 55 | 154 | 4 | EFO_0009925 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 2.29e-04 | 23 | 154 | 3 | C1708353 | |
| Disease | pulmonary embolism (is_implicated_in) | 2.68e-04 | 5 | 154 | 2 | DOID:9477 (is_implicated_in) | |
| Disease | hair colour measurement | PODXL TRIM41 TOM1 NR6A1 ADGRV1 AXIN2 FREM2 ZNF469 KMT2D MITF FTO | 4.04e-04 | 615 | 154 | 11 | EFO_0007822 |
| Disease | lung small cell carcinoma (is_implicated_in) | 4.15e-04 | 28 | 154 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | melanoma (is_marker_for) | 6.78e-04 | 33 | 154 | 3 | DOID:1909 (is_marker_for) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 7.42e-04 | 8 | 154 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Obesity | 7.48e-04 | 205 | 154 | 6 | C0028754 | |
| Disease | multiple myeloma (is_marker_for) | 8.77e-04 | 36 | 154 | 3 | DOID:9538 (is_marker_for) | |
| Disease | Colorectal Carcinoma | RALGDS ANK2 ZBTB8B STK32C F5 AXIN2 LPIN1 RPAP1 SACS PTPRS VPS13A | 1.19e-03 | 702 | 154 | 11 | C0009402 |
| Disease | nevus count, cutaneous melanoma | 1.34e-03 | 91 | 154 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | ceramide measurement | 1.51e-03 | 235 | 154 | 6 | EFO_0010222 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 1.70e-03 | 97 | 154 | 4 | EFO_0007878, EFO_0009458 | |
| Disease | Oligospermia | 1.73e-03 | 12 | 154 | 2 | C0028960 | |
| Disease | intracranial aneurysm (is_implicated_in) | 1.73e-03 | 12 | 154 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | colon carcinoma (is_marker_for) | 2.03e-03 | 13 | 154 | 2 | DOID:1520 (is_marker_for) | |
| Disease | prostate carcinoma (is_implicated_in) | 2.03e-03 | 13 | 154 | 2 | DOID:10286 (is_implicated_in) | |
| Disease | asthma, body mass index | 2.36e-03 | 14 | 154 | 2 | EFO_0004340, MONDO_0004979 | |
| Disease | 5-methyluridine (ribothymidine) measurement | 2.36e-03 | 14 | 154 | 2 | EFO_0020013 | |
| Disease | body weight | COPB1 EPB41L4B VPS13C ESR1 HDX CAST WASHC3 ADGRV1 AXIN2 SUSD1 UBXN7 PCDH15 FTO NUTM2F PHACTR1 | 2.55e-03 | 1261 | 154 | 15 | EFO_0004338 |
| Disease | Down syndrome (implicated_via_orthology) | 2.72e-03 | 15 | 154 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | response to platinum based chemotherapy, magnesium measurement | 2.72e-03 | 15 | 154 | 2 | EFO_0004647, EFO_0004845 | |
| Disease | anemia (implicated_via_orthology) | 2.72e-03 | 15 | 154 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | peripheral arterial disease | 2.85e-03 | 54 | 154 | 3 | EFO_0004265 | |
| Disease | Acute Cerebrovascular Accidents | 2.85e-03 | 54 | 154 | 3 | C0751956 | |
| Disease | response to acetylsalicylate | 3.10e-03 | 16 | 154 | 2 | GO_1903492 | |
| Disease | von Willebrand factor measurement | 3.16e-03 | 56 | 154 | 3 | EFO_0004629 | |
| Disease | non-Hodgkin lymphoma (is_implicated_in) | 3.50e-03 | 17 | 154 | 2 | DOID:0060060 (is_implicated_in) | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 3.58e-03 | 194 | 154 | 5 | EFO_0004265, EFO_0007908 | |
| Disease | cutaneous melanoma | 3.78e-03 | 121 | 154 | 4 | EFO_0000389 | |
| Disease | Brain Ischemia | 3.84e-03 | 60 | 154 | 3 | C0007786 | |
| Disease | Cerebral Ischemia | 3.84e-03 | 60 | 154 | 3 | C0917798 | |
| Disease | migraine disorder, systolic blood pressure | 3.92e-03 | 18 | 154 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | response to opioid | 4.02e-03 | 61 | 154 | 3 | EFO_0008541 | |
| Disease | age at menarche | 4.11e-03 | 594 | 154 | 9 | EFO_0004703 | |
| Disease | Depressive disorder | 4.21e-03 | 289 | 154 | 6 | C0011581 | |
| Disease | Cerebrovascular accident | 4.21e-03 | 62 | 154 | 3 | C0038454 | |
| Disease | IGF-1 measurement | 4.23e-03 | 488 | 154 | 8 | EFO_0004627 | |
| Disease | Malignant Neoplasms | 4.61e-03 | 128 | 154 | 4 | C0006826 | |
| Disease | Deaf Mutism | 4.83e-03 | 20 | 154 | 2 | C4082305 | |
| Disease | Deafness, Acquired | 4.83e-03 | 20 | 154 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 4.83e-03 | 20 | 154 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 4.83e-03 | 20 | 154 | 2 | C0581883 | |
| Disease | Bilateral Deafness | 4.83e-03 | 20 | 154 | 2 | C3665473 | |
| Disease | coagulation factor V measurement | 4.83e-03 | 20 | 154 | 2 | EFO_0008087 | |
| Disease | Lymphoma, Follicular | 4.83e-03 | 20 | 154 | 2 | C0024301 | |
| Disease | Prelingual Deafness | 4.83e-03 | 20 | 154 | 2 | C0011052 | |
| Disease | breast carcinoma (is_marker_for) | 5.02e-03 | 66 | 154 | 3 | DOID:3459 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DPVLDEKSPLLDMEL | 61 | Q96BA8 | |
| EMPADLPSLAADFVE | 321 | P02768 | |
| QEPETLLAAMRPSEE | 206 | Q6ZTN6 | |
| KPELLEEMEASPTEL | 2906 | P13611 | |
| ALDPEAEPSMDVILV | 6 | Q9UJW3 | |
| ELVALMADSVLSDSP | 76 | Q9HD36 | |
| LDALLGIDDLETMPD | 96 | P18848 | |
| AVPADLAEMAREPAE | 206 | P0C2W7 | |
| EALPAPSDDATALMT | 131 | P07203 | |
| DEDLDLIPPKPMASS | 166 | Q5XKK7 | |
| NLTVSILPDDFPEMD | 2521 | Q8WXG9 | |
| LDPDTLPAVATLLMD | 191 | A6NHX0 | |
| MDLEGPRDILVPSED | 16 | O96018 | |
| STDVLATVLEEMPPF | 591 | O95782 | |
| EMTPVEPATFAAELI | 361 | Q9Y2T1 | |
| LESQAVEALDLPMPG | 471 | O14490 | |
| SETIPMVVSDFDLPD | 1086 | Q5JWR5 | |
| PSLEDVESMNDFDPL | 401 | Q9H9F9 | |
| ELLEMEPETAKFSPA | 1856 | Q9UPY3 | |
| PSIEEADILPIMLSE | 766 | Q9UKL3 | |
| APPEALSSEMSELSA | 591 | Q9P1Y5 | |
| LMELVGQEPESALPD | 246 | Q8IZY2 | |
| MEEKELLSPLSEPDD | 696 | Q9UHB7 | |
| MEEDSLEDSNLPPKV | 1 | Q9H095 | |
| ILSDPEALAAMQDPE | 316 | Q8NFI4 | |
| ILSDPEVLAAMQDPE | 316 | P50502 | |
| AVADMLDIPILGSEP | 586 | Q86VS3 | |
| APLGLMDTPLLDTEE | 156 | Q17RG1 | |
| PVLASPDLLSEVSEM | 1496 | Q01484 | |
| LEPLDSEEPSETMGL | 56 | Q9NZ53 | |
| TEDLMTFLDDDPELP | 236 | Q8IYW4 | |
| DMLDASLEPETTSAP | 9476 | Q8WXI7 | |
| ILDTPQAADLDEFPM | 376 | Q6TGC4 | |
| PEEAEDRFSMPLIIT | 451 | O00592 | |
| LEVPVSDLLEDMFSL | 376 | Q8NF37 | |
| SMVLPEVEAALAEIP | 186 | Q96CN7 | |
| LLSDLPPELEEMDFN | 651 | Q7Z353 | |
| ESISDTTDLALPPEM | 611 | Q86WA8 | |
| MADLSLADALTEPSP | 1 | P27816 | |
| ETEVALARDMTLPPE | 441 | P27816 | |
| DSTPELDMCPETRLD | 346 | Q9UPT6 | |
| MLVIPPGLSEEEEAL | 1 | P18615 | |
| ITADLSLPMAPESAA | 966 | Q2M2H8 | |
| TLEMLAGDPLLSEDP | 36 | Q9P107 | |
| ASMPLPFDLTDIVSE | 481 | Q9C0B1 | |
| QPLAEDMEALSLPEL | 511 | Q9Y3R5 | |
| PEMALLTALDDTLPE | 26 | Q96PT3 | |
| TDDLMLTFLLEDPPL | 976 | Q5SZK8 | |
| TAAMIDAVLDELPPL | 686 | Q86VP6 | |
| IESLATMEPDSRPEL | 1816 | Q5VYK3 | |
| TEKVDLELFPSPDME | 16 | P14921 | |
| TADQMVSALLDAEPP | 311 | P03372 | |
| MLEESDCPSPLELKS | 11 | Q01064 | |
| MDSEPPSEISLKNDL | 16 | P53618 | |
| TPSLLSEADLIPDVM | 346 | Q9H8E8 | |
| GILDLEETEMPEPLA | 2596 | O94915 | |
| EDLETLGAAAPLLPM | 346 | Q14693 | |
| AASLLAPMDVGEEPL | 46 | P22413 | |
| PSELADELPDMTLDK | 91 | Q7Z3K6 | |
| TMPEVKDLSEALPET | 31 | Q9H7P6 | |
| KDLSEALPETSMDPI | 36 | Q9H7P6 | |
| TPLGSPEDMDLEELI | 1171 | Q13332 | |
| LLPPTLMAASSEDDI | 41 | Q9C0D0 | |
| VDPLLALLAVPDMSS | 206 | P52292 | |
| DDPTSNDTFEIPLML | 196 | Q96QU1 | |
| FESSPELVEKEPMLA | 446 | B2RXH4 | |
| ASLLPTPVDDDEIDM | 451 | A2A2Y4 | |
| EDLDMDIVSVPSSVP | 511 | P46100 | |
| TAMTAEPEPELDLES | 471 | A4D2P6 | |
| SMSEEFLALPLEDVL | 171 | O94889 | |
| LPEDSSAVDMDILFP | 6 | A6NFR6 | |
| ELLEELMSSEVFAPL | 366 | Q16254 | |
| DIIDELMSSDVFPLL | 301 | Q15329 | |
| SEDKMSPASPIDDIE | 146 | Q96CJ1 | |
| PASSLDDVFLPKDMD | 841 | Q96PV7 | |
| MEPTAPSLTEEDLTE | 1 | O95999 | |
| LMSTSEVLEPEHELP | 1516 | Q8N3K9 | |
| SQDEELLMPPDALTD | 801 | Q5T3F8 | |
| KISVEDADEPPMFLA | 371 | P55287 | |
| PAMALLTALDDTLPE | 26 | Q96PT4 | |
| EQLPPMSEDFLLDAL | 501 | P20810 | |
| PPDLVAEQFTLMDAE | 386 | Q12967 | |
| MALLTALDDTLPEEA | 1 | O43812 | |
| VLSVPDDLEAGPMDL | 376 | Q9H9L4 | |
| LPELMAEKDSLDPSF | 6 | O75525 | |
| VLMTFEPDPADLALS | 201 | Q10586 | |
| LSMVILLPDDIEDES | 226 | P30740 | |
| DLDVVLTPMLAPALD | 466 | O00519 | |
| MEEALPSAPERLALD | 166 | Q96KS0 | |
| MLIVSDIDDVFLPTP | 741 | O95487 | |
| SEDLTLFDEMPLIPR | 791 | Q9NZJ4 | |
| LTDSEDESPEDMRLP | 536 | Q9P1Z2 | |
| PIMLIATEPDTDAVI | 3026 | Q6ZTR5 | |
| DLLMDFTEATPLAEP | 756 | Q9H329 | |
| DAMEDVHSLLTDVPP | 686 | Q86YS7 | |
| ELVSLITQDPPLDME | 56 | O75170 | |
| LLETIPPELAGMESL | 231 | Q9H9A6 | |
| ELAPAPLDSDMPLLD | 521 | Q03933 | |
| SEPEIDLEALMDLST | 91 | Q9NXH3 | |
| DVSMFLLLPDEIADV | 261 | P05120 | |
| LEELLSPDPQMDFLA | 516 | Q5VT03 | |
| LEELLSPDPQMDFLA | 466 | A1L443 | |
| LEELLSPDPQMDFLA | 451 | Q5VZR2 | |
| QLLSAEDLEPLGTPM | 256 | Q15406 | |
| MADPDVLTEVPAALK | 1 | P29083 | |
| STMEPEAPDLDLVEI | 381 | Q9Y5X1 | |
| VDLTLDPDTAHPALM | 431 | Q8WV44 | |
| DSINILADVLPEEMP | 536 | Q9ULQ0 | |
| PDLSEMPLFADLSQI | 1386 | P12259 | |
| MLDDFPDTLPSPEAL | 276 | Q86YW0 | |
| SDIEDVFIPMPENLL | 571 | O95486 | |
| MTDLPELDTPESARI | 1021 | O95486 | |
| LEEAELESLDPMTPG | 1626 | P21675 | |
| MSLIDDDFSLEPLIS | 796 | Q96D09 | |
| SLMVDANIPDIALEP | 821 | Q8NEB9 | |
| MPAEIVVLLDSEDNP | 171 | Q9BUA3 | |
| DSSDEERIPMLVTPA | 36 | Q9NWF9 | |
| IRELFDMPLEEPSSS | 2206 | Q6ZRS2 | |
| EAMEEILTSSEPLDP | 381 | Q12765 | |
| PTFELEEMILESRPL | 381 | Q86UX6 | |
| VDLSAPKVEADMSLP | 1351 | Q8IVF2 | |
| EMPEALEFSLSANPE | 71 | A6NIR3 | |
| AMLPPNVIDTDFIDE | 211 | Q99967 | |
| DPREAADLDAVPMSL | 451 | Q6IBW4 | |
| ASPALIMLTEEDPIL | 221 | P48995 | |
| SAPDRLESMEVDLSP | 151 | Q495C1 | |
| SEILPEMASQFPEEI | 5171 | Q63HN8 | |
| SQLMDADLEVSLVPP | 106 | A6NLX4 | |
| GPMTPESALEELLAV | 101 | P0CW01 | |
| GPMTPESALEELLAV | 101 | A6NKD2 | |
| MSEASSEDLVPPLEA | 1 | Q03169 | |
| PETLEEMLTPEEKAL | 451 | Q96RL7 | |
| SEPMAVPDLDIELEL | 336 | Q86XK7 | |
| LLPFLEEPMDTEADL | 131 | O43242 | |
| MDDTLSPVGVTDPLL | 486 | O75030 | |
| EMLAAAAEPTLRPDI | 716 | Q9BYB0 | |
| LAIDPLLDAAPVDMA | 171 | Q8N2H3 | |
| SALQSHPEEEPLLVM | 421 | Q8NE28 | |
| PETRTDAAMSELVPE | 6 | Q9UH03 | |
| NRPLSDEELDAMFPE | 396 | O75533 | |
| EMLTELVPTQAEPAD | 236 | O60784 | |
| KAPSEAEPAADLIDM | 311 | O60784 | |
| LEVLEDLMEVSSPSP | 501 | Q6ZMY3 | |
| ELLAKDVPDDAMEIP | 656 | Q6UWL2 | |
| DDIRALLIDAMPPEA | 946 | O95271 | |
| SDAPDEFRDPLMDTL | 1226 | O95155 | |
| RMLASPAPEDEEKLA | 151 | Q8TBP0 | |
| DEAPNPTLFTEMDTL | 106 | Q9BY07 | |
| LIPETIDDLMTPEEK | 491 | Q709C8 | |
| SEDMPESLPEAEQLL | 1086 | P11277 | |
| DTEEMEALLPQAPAS | 251 | A6NFE2 | |
| EEPEMESLFPALASL | 891 | Q2NKQ1 | |
| ALPPEEAEMLSTEAL | 661 | Q9BWH6 | |
| GPMTPESALEELLAV | 101 | P0CV98 | |
| GPMTPESALEELLAV | 101 | P0CW00 | |
| PLPASDLDMEDDAKL | 826 | Q96JG9 | |
| EMADPDLLEESSSLL | 141 | Q93050 | |
| ITFEAPELPEETLME | 806 | Q8IYT8 | |
| PPSHVVDLLDSIEDM | 126 | Q9NRH1 | |
| AVDSEILEMPPEKAD | 386 | O94888 | |
| LVMTPDPEFLVSEAE | 301 | Q5VWN6 | |
| LPMTEEELAALAAEA | 166 | Q00G26 | |
| AASMPALDSEDAPVR | 366 | Q53EQ6 | |
| DRLTVMELPSPESEE | 36 | O75123 | |
| MISEGLDPDLLERPD | 156 | Q9Y3C0 | |
| VPELMDTASLEPGAL | 361 | Q96QC0 | |
| PLEMAVSEPEASAAE | 31 | Q9Y6Q3 | |
| DMLEPEAELAEDLPT | 481 | Q6P2D8 | |
| PDDDDDLMPINLSLV | 431 | Q8NAP8 | |
| PEDSLMSLPLEESPL | 711 | O14686 |